JP2009534368A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534368A5
JP2009534368A5 JP2009505983A JP2009505983A JP2009534368A5 JP 2009534368 A5 JP2009534368 A5 JP 2009534368A5 JP 2009505983 A JP2009505983 A JP 2009505983A JP 2009505983 A JP2009505983 A JP 2009505983A JP 2009534368 A5 JP2009534368 A5 JP 2009534368A5
Authority
JP
Japan
Prior art keywords
group
propoxyethyl
pyrido
alkyl
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009505983A
Other languages
English (en)
Japanese (ja)
Other versions
JP4436892B2 (ja
JP2009534368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/001001 external-priority patent/WO2007122466A1/en
Publication of JP2009534368A publication Critical patent/JP2009534368A/ja
Publication of JP2009534368A5 publication Critical patent/JP2009534368A5/ja
Application granted granted Critical
Publication of JP4436892B2 publication Critical patent/JP4436892B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009505983A 2006-04-21 2007-04-10 ピリジン[3,4−b]ピラジノン Expired - Fee Related JP4436892B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79397106P 2006-04-21 2006-04-21
PCT/IB2007/001001 WO2007122466A1 (en) 2006-04-21 2007-04-10 Pyridine[3,4-b]pyrazinones

Publications (3)

Publication Number Publication Date
JP2009534368A JP2009534368A (ja) 2009-09-24
JP2009534368A5 true JP2009534368A5 (https=) 2009-11-05
JP4436892B2 JP4436892B2 (ja) 2010-03-24

Family

ID=38431249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009505983A Expired - Fee Related JP4436892B2 (ja) 2006-04-21 2007-04-10 ピリジン[3,4−b]ピラジノン

Country Status (41)

Country Link
US (1) US7902195B2 (https=)
EP (1) EP2013208B1 (https=)
JP (1) JP4436892B2 (https=)
KR (1) KR101061328B1 (https=)
CN (1) CN101454320B (https=)
AP (1) AP2408A (https=)
AR (1) AR060525A1 (https=)
AT (1) ATE513831T1 (https=)
AU (1) AU2007242555B2 (https=)
BR (1) BRPI0710658A2 (https=)
CA (1) CA2649775C (https=)
CR (1) CR10327A (https=)
CU (1) CU23777B7 (https=)
CY (1) CY1111739T1 (https=)
DK (1) DK2013208T3 (https=)
DO (1) DOP2007000080A (https=)
EA (1) EA014919B1 (https=)
EC (1) ECSP088803A (https=)
ES (1) ES2366239T3 (https=)
GT (1) GT200700035A (https=)
HR (1) HRP20110539T1 (https=)
IL (1) IL194591A (https=)
MA (1) MA30352B1 (https=)
ME (1) MEP23808A (https=)
MX (1) MX2008012456A (https=)
MY (1) MY148583A (https=)
NL (1) NL2000583C2 (https=)
NO (1) NO20084129L (https=)
NZ (1) NZ571540A (https=)
PA (1) PA8724201A1 (https=)
PE (1) PE20080192A1 (https=)
PL (1) PL2013208T3 (https=)
RS (2) RS51885B (https=)
SI (1) SI2013208T1 (https=)
SV (1) SV2008003074A (https=)
TN (1) TNSN08408A1 (https=)
TW (1) TWI337609B (https=)
UA (1) UA92637C2 (https=)
UY (1) UY30291A1 (https=)
WO (1) WO2007122466A1 (https=)
ZA (1) ZA200808283B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007242555B2 (en) 2006-04-21 2010-12-16 Pfizer Products Inc. Pyridine[3,4-b]pyrazinones
HUE025355T2 (en) 2006-12-12 2016-02-29 Gilead Sciences Inc Composition for treating pulmonary hypertension
PT2247292T (pt) 2008-03-05 2017-07-17 Merck Patent Gmbh Derivados de piridopirazinonas como estimulantes da secreção de insulina, procedimentos para a sua obtenção e a sua utilização no tratamento da diabetes
WO2010041711A1 (ja) * 2008-10-09 2010-04-15 杏林製薬株式会社 イソキノリン誘導体及びそれらを有効成分とするpde阻害剤
SG10201500511TA (en) * 2009-10-26 2015-03-30 Signal Pharm Llc Methods Of Synthesis And Purification Of Heteroaryl Compounds
MX346730B (es) 2010-10-15 2017-03-30 Gilead Sciences Inc Composiciones y metodos para el tratamiento de la hipertension pulmonar.
CA2830027C (en) 2011-03-31 2016-04-26 Pfizer Inc. Novel bicyclic pyridinones
WO2012172449A1 (en) 2011-06-13 2012-12-20 Pfizer Inc. Lactams as beta secretase inhibitors
JP6043355B2 (ja) 2011-08-31 2016-12-14 ファイザー・インク ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物
WO2013164730A1 (en) 2012-05-04 2013-11-07 Pfizer Inc. Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
EP2897964A1 (en) 2012-09-20 2015-07-29 Pfizer Inc. Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
EP2931731A1 (en) 2012-12-11 2015-10-21 Pfizer Inc. Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
US9403846B2 (en) 2012-12-19 2016-08-02 Pfizer Inc. Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
EP2956458B1 (en) 2013-02-13 2017-08-09 Pfizer Inc Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
US9233981B1 (en) 2013-02-15 2016-01-12 Pfizer Inc. Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
BR112015019276A2 (pt) 2013-02-19 2017-07-18 Pfizer compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
JP6425717B2 (ja) 2013-10-04 2018-11-21 ファイザー・インク ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン
JO3466B1 (ar) * 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
AP2016009465A0 (en) 2014-04-01 2016-09-30 Pfizer Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators
CN106459088A (zh) 2014-04-10 2017-02-22 辉瑞公司 2‑氨基‑6‑甲基‑4,4a,5,6‑四氢吡喃并[3,4‑d][1,3]噻嗪‑8a(8H)‑基‑1,3‑噻唑‑4‑基酰胺
WO2016012896A1 (en) 2014-07-24 2016-01-28 Pfizer Inc. Pyrazolopyrimidine compounds
MD20170011A2 (ro) 2014-08-06 2017-08-31 Pfizer Inc. Compuşi imidazopiridazinici
MX368391B (es) 2015-02-03 2019-09-30 Pfizer Ciclopropabenzofuranil-piridopirazindionas novedosas.
CN107787322B (zh) 2015-06-17 2023-07-07 辉瑞大药厂 三环化合物以及它们作为磷酸二酯酶抑制剂的用途
JP2018531923A (ja) 2015-09-24 2018-11-01 ファイザー・インク N−[2−(2−アミノ−6,6−二置換−4,4a,5,6−テトラヒドロピラノ[3,4−d][1,3]チアジン−8a(8H)−イル)−1,3−チアゾール−4−イル]アミド
WO2017051303A1 (en) 2015-09-24 2017-03-30 Pfizer Inc. Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
JP2018534251A (ja) 2015-09-24 2018-11-22 ファイザー・インク Bace阻害剤として有用なn−[2−(3−アミノ−2,5−ジメチル−1,1−ジオキシド−5,6−ジヒドロ−2h−1,2,4−チアジアジン−5−イル)−1,3−チアゾール−4−イル]アミド
CN113332292A (zh) 2016-02-23 2021-09-03 辉瑞公司 6,7-二氢-5H-吡唑并[5,1-b][1,3]噁嗪-2-甲酰胺化合物
PT3478679T (pt) 2016-07-01 2021-06-30 Pfizer Derivados de 5,7-dihidro-pirrolo-piridina para o tratamento de doenças neurológicas e neurodegenerativas
IL271290B2 (en) 2017-06-22 2023-11-01 Pfizer Dihydro-pyrrolo-pyridine derivatives
US11382918B2 (en) * 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
PT3768669T (pt) 2018-03-23 2023-04-24 Pfizer Derivados de piperazina azaspiro
US12144815B2 (en) 2021-02-23 2024-11-19 Hoth Therapeutics, Inc. Use of aprepitant for treating Alzheimer's disease
WO2024118524A1 (en) 2022-11-28 2024-06-06 Cerevel Therapeutics, Llc Azaindole compounds and their use as phosphodiesterase inhibitors
WO2025145091A1 (en) 2023-12-29 2025-07-03 Pfizer Inc. Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases
WO2025160132A1 (en) * 2024-01-23 2025-07-31 Maplight Therapeutics, Inc. Gpr6 inverse agonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1361652A (fr) 1963-06-21 1964-05-22 Ciba Geigy Procédé de préparation de diazines, entre autres de la 2-méthyl-6-hydroxy-7-morpholino-ptéridine
HU221425B (en) 1990-11-06 2002-10-28 Yamanouchi Pharma Co Ltd Condensed pyrazine derivatives, process for their production and pharmaceutical preparations containing these compounds
TW274550B (https=) 1992-09-26 1996-04-21 Hoechst Ag
JP2000154139A (ja) 1998-09-16 2000-06-06 Kyowa Hakko Kogyo Co Ltd 縮環ピラジン誘導体
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6465465B1 (en) * 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
JP4166991B2 (ja) * 2001-02-26 2008-10-15 田辺三菱製薬株式会社 ピリドピリミジンまたはナフチリジン誘導体
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030114469A1 (en) * 2001-09-27 2003-06-19 Cohen David Saul Combinations
US7067658B2 (en) 2002-09-30 2006-06-27 Bristol-Myers Squibb Company Pyridino and pyrimidino pyrazinones
JP2007504283A (ja) 2003-05-20 2007-03-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア β−アミロイド斑に作用物質を結合させる方法
EP1641423B1 (en) 2003-06-26 2010-03-17 Merck Sharp & Dohme Corp. Benzodiazepine cgrp receptor antagonists
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
EP1833803A4 (en) 2005-01-03 2009-08-05 Myriad Genetics Inc PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCTORS OF APOPTOSIS AND THEIR USE
CA2608672A1 (en) * 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
JP2009509923A (ja) 2005-08-26 2009-03-12 メシルジーン、インコーポレイテッド ヒストンデアセチラーゼのベンゾジアゼピン及びベンゾピペラジン類似体阻害薬
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
AU2007242555B2 (en) 2006-04-21 2010-12-16 Pfizer Products Inc. Pyridine[3,4-b]pyrazinones

Similar Documents

Publication Publication Date Title
JP2009534368A5 (https=)
CA2649775A1 (en) Pyridine[3,4-b]pyrazinones
KR101562835B1 (ko) 치료제
AP910A (en) Indazole bioisostere replacement of catechol in therapeutically active compounds.
JP6236173B2 (ja) 脊髄性筋萎縮症を処置するための化合物
JP2009524676A5 (https=)
JP2014037426A5 (https=)
JP2005516067A5 (https=)
JP2011500758A5 (https=)
JP2011520832A5 (https=)
CN101263130A (zh) 2-苯胺-4-芳基取代的噻唑衍生物
JP2007522098A5 (https=)
JP2013509392A5 (https=)
JP2012526736A5 (https=)
WO2004087677A3 (en) Pyrimidin-4-one derivatives and their use as p38 kinase modulators
EA023824B1 (ru) ПРОИЗВОДНЫЕ 3,4-ДИГИДРОПИРРОЛО[1,2-a]ПИРАЗИН-1-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
WO2005018557A3 (en) Substituted pyridinones
RU96103653A (ru) Бициклические тетрагидропиразолопиридины
CN102858177A (zh) 儿茶酚-o-甲基转移酶抑制剂及其在治疗精神障碍中的用途
JP2008505107A5 (https=)
US9550750B2 (en) Indoline compounds as aldosterone synthase inhibitors
US20110003862A1 (en) 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases
JP2004507527A5 (https=)
JP2007520539A5 (https=)
CA2354606A1 (en) Azabicycloalkane derivatives and therapeutic uses thereof